Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Belinostat

EU orphan designation number: EU/3/12/1055   
Active ingredient: Belinostat
Indication: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Sponsor: TopoTarget A/S
Fruebjergvej 3, DK-2100 KÝbenhavn, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2012 Centralised Orphan - Designation EMA/OD/103/12 (2012)7232 of 10/10/2012